S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Critical asset just had biggest fall on record (Ad)
AI powerhouse NVIDIA will hit $1000 soon
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
AI Stock Caught Trading Under Secret Name (Ad)
Roku stock and the mother of all entry opportunities
Rivian shares gets discounted; shares can move lower 
AI Stock Caught Trading Under Secret Name (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Critical asset just had biggest fall on record (Ad)
AI powerhouse NVIDIA will hit $1000 soon
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
AI Stock Caught Trading Under Secret Name (Ad)
Roku stock and the mother of all entry opportunities
Rivian shares gets discounted; shares can move lower 
AI Stock Caught Trading Under Secret Name (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Critical asset just had biggest fall on record (Ad)
AI powerhouse NVIDIA will hit $1000 soon
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
AI Stock Caught Trading Under Secret Name (Ad)
Roku stock and the mother of all entry opportunities
Rivian shares gets discounted; shares can move lower 
AI Stock Caught Trading Under Secret Name (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Critical asset just had biggest fall on record (Ad)
AI powerhouse NVIDIA will hit $1000 soon
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
AI Stock Caught Trading Under Secret Name (Ad)
Roku stock and the mother of all entry opportunities
Rivian shares gets discounted; shares can move lower 
AI Stock Caught Trading Under Secret Name (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard

Arrowhead Pharmaceuticals (ARWR) News Today

$30.20
+1.02 (+3.50%)
(As of 02/22/2024 ET)
SourceHeadline
marketbeat.com logoCitigroup Inc. Has $4.35 Million Stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
marketbeat.com - February 21 at 5:43 AM
MarketBeat logoArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives Average Recommendation of "Moderate Buy" from Brokerages
americanbankingnews.com - February 21 at 1:40 AM
marketbeat.com logoAigen Investment Management LP Acquires 25,120 Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
marketbeat.com - February 20 at 8:39 AM
marketbeat.com logoRafferty Asset Management LLC Has $8 Million Stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
marketbeat.com - February 18 at 7:28 AM
marketbeat.com logoState of New Jersey Common Pension Fund D Boosts Holdings in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
marketbeat.com - February 17 at 6:46 AM
ca.finance.yahoo.com logoARWR Mar 2024 30.000 call
ca.finance.yahoo.com - February 17 at 2:37 AM
MarketBeat logoArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Forecasted to Earn FY2025 Earnings of ($3.51) Per Share
americanbankingnews.com - February 14 at 3:32 AM
nasdaq.com logoArrowhead Pharmaceuticals, Inc. Common Stock (ARWR)
nasdaq.com - February 12 at 5:49 PM
marketbeat.com logoArrowhead Pharmaceuticals (NASDAQ:ARWR) Shares Down 2.6%
marketbeat.com - February 12 at 4:03 PM
marketbeat.com logoArrowhead Pharmaceuticals, Inc. to Post FY2025 Earnings of ($3.51) Per Share, Chardan Capital Forecasts (NASDAQ:ARWR)
marketbeat.com - February 12 at 3:23 AM
marketbeat.com logoArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Shares Sold by Barclays PLC
marketbeat.com - February 10 at 4:40 AM
marketbeat.com logoFY2024 EPS Estimates for Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Increased by Analyst
marketbeat.com - February 9 at 7:36 AM
markets.businessinsider.com logoBuy Rating Affirmed for Arrowhead Pharmaceuticals with Strong Growth Projections and Pipeline Potential
markets.businessinsider.com - February 8 at 5:44 PM
markets.businessinsider.com logoStrategic Developments and Financial Strength Underpin Buy Rating for Arrowhead Pharmaceuticals
markets.businessinsider.com - February 8 at 12:44 PM
finance.yahoo.com logoARWR: Pipeline Reprioritization to Reduce Cash Burn by up to $100 Million This Fiscal Year
finance.yahoo.com - February 8 at 12:44 PM
marketbeat.com logoMorgan Stanley Increases Arrowhead Pharmaceuticals (NASDAQ:ARWR) Price Target to $36.00
marketbeat.com - February 8 at 8:16 AM
finance.yahoo.com logoArrowhead Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations
finance.yahoo.com - February 8 at 7:44 AM
markets.businessinsider.com logoArrowhead Pharmaceuticals: Strategic Cost-Cutting and Resource Allocation to Bolster Commercial Transition
markets.businessinsider.com - February 7 at 4:41 PM
marketbeat.com logoArrowhead Pharmaceuticals (NASDAQ:ARWR) PT Raised to $34.00
marketbeat.com - February 7 at 2:52 PM
marketbeat.com logoArrowhead Pharmaceuticals (NASDAQ:ARWR) Rating Reiterated by Royal Bank of Canada
marketbeat.com - February 7 at 12:41 PM
markets.businessinsider.com logoAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR), Edwards Lifesciences (EW) and Doximity (DOCS)
markets.businessinsider.com - February 7 at 10:05 AM
finance.yahoo.com logoQ1 2024 Arrowhead Pharmaceuticals Inc Earnings Call
finance.yahoo.com - February 7 at 10:05 AM
marketbeat.com logoArrowhead Pharmaceuticals (NASDAQ:ARWR) Announces Earnings Results
marketbeat.com - February 7 at 9:50 AM
finance.yahoo.com logoArrowhead Pharmaceuticals Inc Reports Fiscal Q1 2024 Results with Strategic Focus on ...
finance.yahoo.com - February 6 at 8:20 PM
msn.com logoArrowhead stock slides 6% as fiscal Q1 report falls short of estimates
msn.com - February 6 at 8:20 PM
msn.com logoArrowhead Pharmaceuticals Q1 2024 Earnings Preview
msn.com - February 5 at 8:35 PM
marketbeat.com logoInsider Selling: Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) CEO Sells 57,499 Shares of Stock
marketbeat.com - February 2 at 6:39 PM
marketbeat.com logoJump Financial LLC Buys 86,807 Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
marketbeat.com - January 31 at 7:49 AM
marketbeat.com logoArrowhead Pharmaceuticals (ARWR) Scheduled to Post Quarterly Earnings on Tuesday
marketbeat.com - January 30 at 3:47 AM
marketbeat.com logoAssenagon Asset Management S.A. Has $11.30 Million Stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
marketbeat.com - January 29 at 6:41 AM
marketbeat.com logoShort Interest in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Expands By 18.7%
marketbeat.com - January 28 at 4:40 AM
marketbeat.com logoArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives Consensus Rating of "Moderate Buy" from Brokerages
marketbeat.com - January 27 at 2:54 AM
finance.yahoo.com logoArrowhead Pharmaceuticals to Webcast Fiscal 2024 First Quarter Results
finance.yahoo.com - January 22 at 7:16 PM
seekingalpha.com logoArrowhead Pharmaceuticals: A Leading Small-Cap Developer Of RNAi Therapy
seekingalpha.com - January 21 at 9:38 AM
marketbeat.com logoBank of New York Mellon Corp Trims Stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
marketbeat.com - January 20 at 4:32 AM
marketbeat.com logoLeerink Partnrs Equities Analysts Decrease Earnings Estimates for Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
marketbeat.com - January 19 at 8:15 AM
marketbeat.com logoArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Shares Sold by Panagora Asset Management Inc.
marketbeat.com - January 18 at 6:45 AM
marketbeat.com logoRoyal Bank of Canada Reaffirms Outperform Rating for Arrowhead Pharmaceuticals (NASDAQ:ARWR)
marketbeat.com - January 16 at 10:23 AM
markets.businessinsider.com logoBuy Rating for Arrowhead Pharmaceuticals Amidst Pipeline Progress and Strategic Financial Positioning
markets.businessinsider.com - January 10 at 5:32 PM
marketbeat.com logoArrowhead Pharmaceuticals (NASDAQ:ARWR) Shares Down 4.8% After Insider Selling
marketbeat.com - January 9 at 1:26 PM
markets.businessinsider.com logoPiper Sandler Reaffirms Their Buy Rating on Arrowhead Pharmaceuticals (ARWR)
markets.businessinsider.com - January 8 at 11:37 PM
marketbeat.com logoInsider Selling: Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) CFO Sells 16,104 Shares of Stock
marketbeat.com - January 8 at 6:30 PM
finance.yahoo.com logoArrowhead Pharmaceuticals Inc Insider Sells Shares
finance.yahoo.com - January 6 at 1:18 PM
businesswire.com logoArrowhead Pharmaceuticals Closes Underwritten Offering with Gross Proceeds of $450.0 Million
businesswire.com - January 5 at 5:03 PM
markets.businessinsider.com logoArrowhead Pharmaceuticals: Strategic Capital Raise Amidst Phase 3 Trials and Market Reaction
markets.businessinsider.com - January 5 at 4:48 PM
marketbeat.com logoResearch Analysts Set Expectations for Arrowhead Pharmaceuticals, Inc.'s FY2025 Earnings (NASDAQ:ARWR)
marketbeat.com - January 5 at 7:47 AM
marketbeat.com logoArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) CEO Christopher Richard Anzalone Sells 9,952 Shares
marketbeat.com - January 4 at 6:54 PM
msn.com logoWhy Arrowhead Pharmaceuticals Shares Are Moving
msn.com - January 3 at 3:42 PM
msn.com logoArrowhead Pharmaceuticals prices $450M common stock offering
msn.com - January 3 at 10:34 AM
markets.businessinsider.com logoArrowhead Pharma Gains 6%, Prices $450 Mln Offering Of Shares
markets.businessinsider.com - January 3 at 10:34 AM
Get Arrowhead Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARWR and its competitors with MarketBeat's FREE daily newsletter.



ARWR Media Mentions By Week

ARWR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ARWR
News Sentiment

1.40

0.48

Average
Medical
News Sentiment

ARWR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ARWR Articles
This Week

6

4

ARWR Articles
Average Week

Get Arrowhead Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARWR and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ARWR) was last updated on 2/23/2024 by MarketBeat.com Staff